Market revenue in 2023 | USD 431.3 million |
Market revenue in 2030 | USD 587.1 million |
Growth rate | 4.5% (CAGR from 2023 to 2030) |
Largest segment | Biomaterials |
Fastest growing segment | Skin-substitutes |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biomaterials, Skin-substitutes, Growth Factors |
Key market players worldwide | Smith & Nephew PLC, MiMedx Group Inc, Organogenesis Holdings Inc Class A, Bic, Integra Lifesciences Holdings Corp, Osiris Corp, Stryker Corp, Tissue Regenix, Cytori Therapeutics, Solsys Medical, Osiris Therapeutics, Human BioSciences |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active wound care market will help companies and investors design strategic landscapes.
Biomaterials was the largest segment with a revenue share of 44.1% in 2023. Horizon Databook has segmented the Europe active wound care market based on biomaterials, skin-substitutes, growth factors covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe active wound care market , including forecasts for subscribers. This continent databook contains high-level insights into Europe active wound care market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account